BRBS · Blue Ridge Bankshares, Inc. · Documents

Jul 25

Current report 8-K

Financial results

Jul 22

Registration statement S-3

Registration statement

Jul 3

Current report 8-K/A Events of Apr 1

Director or officer change, or executive pay

Jun 28

Current report 8-K

Other events

Jun 24

Current report 8-K/A Events of Apr 1

Director or officer change, or executive pay

Jun 24

Current report 8-K Events of Jun 18

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results

Jun 14

Current report 8-K Events of Jun 13

Entered into a material agreement, Unregistered sale of equity

Jun 14

Proxy statement DEFA14A

Proxy statement

Jun 11

Current report 8-K Events of Jun 7

Entered into a material agreement, Unregistered sale of equity

May 8

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Net loss $2.89M Diluted EPS -$0.15

May 7

Proxy statement DEF 14A Meeting Jun 20, 2024

Proxy statement

Apr 30

Current report 8-K

Financial results

Apr 29

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2023

Apr 23

Proxy statement PRE 14A

Proxy statement

Apr 5

Current report 8-K Events of Apr 1

Entered into a material agreement, Unregistered sale of equity, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events

Apr 5

Proxy statement DEFA14A

Proxy statement

Apr 3

Current report 8-K

Other events

Apr 3

Proxy statement DEFA14A

Proxy statement

Mar 15

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Net loss $51.77M Diluted EPS -$2.73

Mar 7

Current report 8-K Events of Mar 6

Shareholder vote results

Feb 13

Proxy statement DEFA14A

Proxy statement

Jan 31

Current report 8-K

Financial results

Jan 31

Proxy statement DEFA14A

Proxy statement

Jan 25

Current report 8-K Events of Jan 24

Entered into a material agreement, Ended a material agreement

Jan 24

Proxy statement DEF 14A Meeting Mar 6, 2024

Proxy statement

Jan 10

Proxy statement PRE 14A

Proxy statement

Dec 22

Current report 8-K Events of Dec 21

Entered into a material agreement, Unregistered sale of equity, Other events

Dec 22

Proxy statement DEFA14A

Proxy statement

Nov 16

Current report 8-K

Regulation FD disclosure

Nov 14

Quarterly report 10-Q/A FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Net income $3.97M ▼ 77.6% Diluted EPS $0.21 ▼ 77.9%

Nov 14

Quarterly report 10-Q/A FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Net loss $8.61M Diluted EPS -$0.45

Nov 14

Annual report 10-K/A FY2022, ended Dec 31

Annual report for FY2022

Net income $17.33M ▼ 67.0% Diluted EPS $0.92 ▼ 68.7%

Nov 14

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Net loss $41.37M Diluted EPS -$2.18

Nov 9

Late filing notice NT 10-Q

Late filing notice

Oct 31

Current report 8-K Events of Oct 30

Other events

Oct 31

Current report 8-K Events of Oct 30

Earlier financial statements no longer reliable

Oct 31

Current report 8-K

Financial results

Oct 26

Current report 8-K Events of Oct 24

Director or officer change, or executive pay

Aug 7

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Net loss $19.46M Diluted EPS -$1.03

Jul 31

Current report 8-K

Financial results

Jul 17

Current report 8-K Events of Jul 12

Director or officer change, or executive pay

Jul 13

Current report 8-K Events of Jul 12

Other events

Jun 15

Current report 8-K Events of Jun 14

Shareholder vote results

May 10

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Net income $1.6M ▼ 91.0% Diluted EPS $0.09 ▼ 90.5%

May 8

Current report 8-K

Other events

May 2

Proxy statement DEFA14A

Proxy statement

Apr 28

Proxy statement DEF 14A Meeting Jun 14, 2023

Proxy statement

Apr 28

Proxy statement DEFA14A

Proxy statement

Apr 27

Current report 8-K

Financial results

Apr 6

Current report 8-K

Other events